Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-26 @ 2:35 AM
Study NCT ID:
NCT05092802
Status:
UNKNOWN
Last Update Posted:
2022-05-03
First Post:
2021-09-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Efficacy of HLX208 (BRAF V600E Inhibitor) for Refractory Primary Brain Tumors With BRAF Mutation After First-line Treatment
Sponsor:
Shanghai Henlius Biotech
Organization: